Fierce Biotech – Enyo Pharma raises $47M to bring hepatitis B, NASH drug to phase 2
Read next in 'Media coverage'
- Fierce Biotech - Enyo Pharma's NASH results show boost in kidney function, differentiating vonafexor from busy field
- Lyon D茅cideurs - Enqu锚te : Lyon, paradis pour les biotechs ?
- La Tribune - La startup de la semaine : comment Enyo Pharma esp猫re gu茅rir l'h茅patite B
- Lyonbiop么le - Lyonbiop么le 1er op茅rateur national du Pass French Tech #healthtech labellise 绿帽社 Pharma et Eye Tech Care
- Les Echos - Enyo Pharma, start-up de l'ann茅e en Auvergne-Rh么ne-Alpes
Latest Press Release 